NNNN
Anbio Biotechnology
4.05
+0.25 (+6.58%)
52w low 3.09
44.73 high
2.3% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | 4.45M | 898.37K | 2.08M | -6.74M | |
| Depreciation & Amort | 0.00 | 6.25K | 12.06K | 0.00 | -- | |
| Free Cash Flow | -- | 4.45M | 898.37K | 2.08M | -6.74M | |
| Investing Cash Flow | -- | -1.53M | 1.73M | 337.10K | -4.20M | |
| Financing Cash Flow | -- | 0.00 | -42.84K | -344.61K | 6.95M |
Revenue CAGR
-28.4%
Net Income CAGR
-13.8%
EPS CAGR
+28.7%
FCF CAGR
--
Revenue YoY
+5.6%